logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > Pharmaceutical Intermediates > (S)-3-Amino-3-phenyl Propionic Acid Methyl Ester Hydrochloride CAS 144494-72-4

(S)-3-Amino-3-phenyl Propionic Acid Methyl Ester Hydrochloride CAS 144494-72-4

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 144494-72-4

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15 days

Payment Terms: T/T, L/C, D/A, Western Union

Supply Ability: TON

Get Best Price
Highlight:
CAS NO::
144494-72-4
Appearance::
Off-white Or White Powder
Molecular Formula::
C10H14ClNO2
Molecular Weight::
215.67700
EINECS NO::
806-563-6
MDL NO::
MFCD11052922
CAS NO::
144494-72-4
Appearance::
Off-white Or White Powder
Molecular Formula::
C10H14ClNO2
Molecular Weight::
215.67700
EINECS NO::
806-563-6
MDL NO::
MFCD11052922
(S)-3-Amino-3-phenyl Propionic Acid Methyl Ester Hydrochloride CAS 144494-72-4

Product Description:

Product Name: (S)-3-Amino-3-phenyl propionic acid methyl ester hydrochloride CAS NO: 144494-72-4

 

 

Synonyms:

3-amino-3-phenylpropionic acid methyl ester hydrochloride;

methyl 3-amino-3-phenylpropionate hydrochloride;

methyl D,L-3-amino-3-phenylpropionate.HCl;

 

 

Chemical & Physical Properties:

Appearance: Off-white or white powder

Assay :≥99.0%

Boiling Point: 317.4℃ at 760 mmHg

Flash Point: 145.8℃

Vapor Pressure: 0.000283mmHg at 25℃

 

 

Safety Information:

Signal Word: Warning

Hazard Statements: H315; H319; H335

Precautionary Statements: P261; P264; P271; P280; P302+P352; P304+P340; P305+P351+P338; P312; P321; P332+P313; P337+P313; P362; P403+P233; P405; P501

 

 

(BETAS) -beta-aminophenilate methyl hydrochloride is an intermediate of dapoxeti-ne, a short-acting selective serotonin reuptake inhibitor (SSRIs) that is currently the only drug approved by the FDA for the treatment of premature ejaculation. It is characterized by on-demand oral administration, rapid onset, short half-life, rapid absorption of 1.5 hours to reach the peak, Chemicalbook primary and secondary PE has similar efficacy. Dapoxeti-ne hydrochloride, originally developed by Johnson & Johnson, was first approved in Finland and Sweden in February 2009 as a treatment for male premature ejaculation. Dapoxeti-ne hydrochloride was approved to be listed in China in 2010 under the trade name of Bilijin. So far, it has been approved for listing in more than 60 countries and regions, including China.

 

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.